Project Grant R01CA297166
Award Date 8/11/25
Completion Date 7/31/30
Dollars Obligated $576K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Ithaca, NY, USA
Similar Awards
- This Project Grant award from the National Cancer Institute (CFDA 93.396 - Cancer Biology Research) provides $700,690.00 to Health Research, Inc. in Buffalo, NY to support research aimed at deciphering the molecular mechanisms of breast cancer bone metastasis. The 5-year project (04/01/2025 - 03/31/2030) seeks to unravel the biological transition from early-stage microscopic bone metastases to established macro-bone metastases, with a focus on understanding the role of the YAP/TAZ...
- The National Cancer Institute (NCI) awarded a $645,323 Project Grant under the Cancer Biology Research program (CFDA 93.396) to Washington University to conduct research on the "Mechanism of Acid Signaling in Bone Organ Metastases on Tumor and Myeloid Cell Evolution Towards Immune Suppression and Tumor Progression." The 5-year research project from February 1, 2025 to January 31, 2030 will investigate how breast cancer cells produce factors that induce an acidic bone marrow...
- The National Cancer Institute (CFDA 93.398 Cancer Research Manpower) awarded a $147,486 Project Grant to the Sloan-Kettering Institute for Cancer Research to support a 3-year research training program in cellular immunology and mechanobiology. The program aims to examine how the mechanical properties of the tumor microenvironment influence metastatic site preference and immune system response. Key research activities include in vivo modeling, biophysical measurements, and single-cell analysis to...
- This $2,691,173.00 Project Grant was awarded on September 24, 2025 by the National Cancer Institute under the Cancer Biology Research program (CFDA 93.396) to the Icahn School of Medicine at Mount Sinai. The grant will support research to determine the mechanisms and impact of the bone-induced factor NRG3 in breast cancer bone metastasis progression, without the occurrence of initial cancer cell dissemination. The research aims to functionally characterize the NRG3 regulome, identify NRG3...
- This $204,027 federal Project Grant award from the National Cancer Institute (CFDA 93.396 - Cancer Biology Research) is supporting the Weill Medical College of Cornell University in expanding single-cell and spatial technologies to link clonal genotypes with phenotypes during cancer evolution. The grant aims to develop advanced single-cell methods that can capture multiple data modalities, including genotypes, transcriptomes, methylomes, and protein expression, to better understand how somatic...
- The U.S. National Cancer Institute awarded a Project Grant in the amount of $1,056,000.00 to the Sloan-Kettering Institute for Cancer Research, a leading cancer research organization located in New York. The grant, awarded under the federal Cancer Treatment Research program (CFDA 93.395), supports research focused on overcoming resistance to targeted therapies in breast cancer. The key objectives of the research project include elucidating the mechanisms underlying breast cancer plasticity and...
- The National Cancer Institute (NCI), a component of the National Institutes of Health, awarded a $413,509 Cooperative Agreement to Cornell University under the Cancer Biology Research program (CFDA 93.396). The project aims to develop a deep learning-based pipeline named PIONEER to generate comprehensive 3D models of the human interactome, addressing a key unmet need in precision oncology. By integrating PIONEER with the PREPPI pipeline, the project will generate atomic-resolution 3D models...
- The National Cancer Institute (CFDA 93.396 - Cancer Biology Research) awarded a $1,625,853 Project Grant to New York University (NYU) on December 13, 2024. The grant will support NYU's research to map and characterize the role of 3D "hubs" - regulatory DNA elements that interact with multiple loci - in the context of T-cell leukemia (T-ALL), early T-cell progenitor leukemia (ETP-ALL), and T-cell lymphoma. The project aims to better define how these 3D chromatin structures are rewired...
- This federal Project Grant award, funded by the National Cancer Institute under the Cancer Biology Research program (CFDA 93.396), supports research focused on understanding the relationship between inflammatory signaling in the leptomeninges and the growth of leptomeningeal metastatic tumors. The $730,398 award to the Sloan-Kettering Institute for Cancer Research, located in New York, will leverage mouse models and single-cell RNA sequencing to investigate how cancer cell signals induce...
- This federal Project Grant award of $1,033,055.00 was provided by the Department of Health and Human Services National Institutes of Health (NIH) under the Trans-NIH Research Support program (CFDA 93.310). The funding supports research aimed at understanding and targeting the mechanisms of cancer metastasis. The project, titled "Targeting Cancer Metastasis by Inhibiting Curvature-Induced Kinase Activation," seeks to unravel the molecular pathways underlying how cancer cells acquire the...